Tabula Rasa HealthCare Inc (TRHC) Receives Consensus Recommendation of “Buy” from Analysts
Shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) have received a consensus rating of “Buy” from the five analysts that are presently covering the company. One equities research analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $17.33.
A number of research firms recently issued reports on TRHC. Stifel Nicolaus decreased their price objective on Tabula Rasa HealthCare from $19.00 to $16.00 and set a “buy” rating for the company in a report on Tuesday, May 2nd. Zacks Investment Research upgraded Tabula Rasa HealthCare from a “sell” rating to a “hold” rating in a report on Thursday, April 13th. Piper Jaffray Companies increased their price objective on Tabula Rasa HealthCare from $18.00 to $19.00 and gave the stock an “overweight” rating in a report on Tuesday, March 14th. Finally, Robert W. Baird set a $17.00 price objective on Tabula Rasa HealthCare and gave the stock a “buy” rating in a report on Thursday, January 19th.
In related news, insider Orsula V. Knowlton sold 8,000 shares of the stock in a transaction dated Wednesday, May 17th. The stock was sold at an average price of $11.94, for a total transaction of $95,520.00. Following the completion of the transaction, the insider now directly owns 919,407 shares in the company, valued at $10,977,719.58. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. TIAA CREF Investment Management LLC increased its position in Tabula Rasa HealthCare by 108.5% in the first quarter. TIAA CREF Investment Management LLC now owns 8,131 shares of the company’s stock worth $110,000 after buying an additional 4,232 shares during the last quarter. Geode Capital Management LLC increased its position in Tabula Rasa HealthCare by 54.4% in the first quarter. Geode Capital Management LLC now owns 32,209 shares of the company’s stock worth $434,000 after buying an additional 11,349 shares in the last quarter. Bank of New York Mellon Corp bought a new position in Tabula Rasa HealthCare during the first quarter worth $178,000. Vanguard Group Inc. increased its position in Tabula Rasa HealthCare by 22.7% in the first quarter. Vanguard Group Inc. now owns 208,967 shares of the company’s stock worth $2,817,000 after buying an additional 38,720 shares in the last quarter. Finally, State Street Corp bought a new position in Tabula Rasa HealthCare during the fourth quarter worth $611,000. Institutional investors and hedge funds own 23.79% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Tabula Rasa HealthCare Inc (TRHC) Receives Consensus Recommendation of “Buy” from Analysts” was published by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2017/05/19/tabula-rasa-healthcare-inc-trhc-receives-consensus-recommendation-of-buy-from-analysts.html.
Shares of Tabula Rasa HealthCare (NASDAQ:TRHC) traded up 1.10% during midday trading on Friday, hitting $11.93. The stock had a trading volume of 59,048 shares. The company’s market capitalization is $205.41 million. The firm’s 50-day moving average is $13.11 and its 200 day moving average is $13.50. Tabula Rasa HealthCare has a one year low of $10.39 and a one year high of $16.85.
Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its quarterly earnings data on Monday, May 1st. The company reported $0.04 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.06 by $0.02. The company had revenue of $27.70 million during the quarter, compared to analyst estimates of $26 million. The firm’s quarterly revenue was up 37.1% compared to the same quarter last year. Equities analysts expect that Tabula Rasa HealthCare will post $0.41 earnings per share for the current fiscal year.
Tabula Rasa HealthCare Company Profile
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.
Receive News & Ratings for Tabula Rasa HealthCare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare Inc and related companies with MarketBeat.com's FREE daily email newsletter.